UpcomingPDUFA target action date

Bezuclastinib

Cogent Biosciences (COGT)

Marketer take

A second indication decision weeks after GIST, which would let one brand team run two launches with very different audiences.

Sponsor company
Cogent Biosciences (COGT)
Indication
Nonadvanced systemic mastocytosis (NonAdvSM)
Therapeutic area
Hematology, Rare disease
Event
PDUFA target action date
Date
Dec 30, 2026
Status
Upcoming
Source
company press release
Last verified
Nov 15, 2026

Dates and status come from the linked public source as of the last verified date. Spot an error or have an update?

Get alerts when FDA dates move